Condition
Moderately to Severely Active Ulcerative Colitis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Moderately to Severely Active Ulcerative Colitis clinical trials that are recruiting, at sites in 9 countries (most in United States (2), Australia (1), Brazil (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 9Countries
All recruiting trials (2)
-
Afimkibart subcutaneous induction in moderately to severely active ulcerative colitis
This study tests whether a subcutaneous induction dose of afimkibart can help people with moderately to severely active ulcerative colitis feel better compared with placebo.
-
Afimkibart for children with moderately to severely active ulcerative colitis
This Phase III study will try Afimkibart to see if it helps children with moderate to severe ulcerative colitis and is safe for them.
Quick answers
How many Moderately to Severely Active Ulcerative Colitis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (2 trials), Australia (1 trial), Brazil (1 trial), Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.